Tp53 and P21 Polymorphisms: Response to Cisplatinum/Paclitaxel-Based Chemotherapy in Ovarian Cancer
AuthID
P-004-NAA
P-004-NAA
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service